Retour
Fourchette du Jour
59,03 €
60,54 €
Fourchette 52 Semaines
29,31 €
70,98 €
Volume
2 105 334
Moyenne 50J / 200J
63,71 €
/
53,26 €
Clôture Précédente
60,95 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,4 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -891,6 | 3,8 |
| Rev Growth 5Y % | 5,7 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
92,27 €
+53.7%
Low: 69,00 €
High: 136,00 €
BPA Prévisionnel
-6,41 €
CA Est.
92 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,37 €
3,31 € – 7,68 €
|
2,2 B | 12 |
| FY2029 |
0,85 €
0,64 € – 1,49 €
|
1,4 B | 8 |
| FY2028 |
-2,36 €
-4,70 € – -0,90 €
|
790 M | 14 |
Points Clés
Revenue grew 5,74% annually over 5 years — modest growth
Negative free cash flow of -534,82M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 370,82%
Croissance
Revenue Growth (5Y)
5,74%
Revenue (1Y)376,56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-73,52%
Net Margin-891,60%
Op. Margin-695,44%
Sécurité
Debt / Equity
N/A
Current Ratio4,53
Interest Coverage-5,89
Valorisation
P/E Ratio
-9,42
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 376,56% | Revenue Growth (3Y) | 241,93% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,74% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 88,04M | Net Income (TTM) | -784,96M |
| ROE | N/A | ROA | -55,10% |
| Gross Margin | 88,50% | Operating Margin | -695,44% |
| Net Margin | -891,60% | Free Cash Flow (TTM) | -534,82M |
| ROIC | -73,52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,53 |
| Interest Coverage | -5,89 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,42 | P/B Ratio | N/A |
| P/S Ratio | 83,97 | PEG Ratio | -0,40 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 7,39B | Enterprise Value | 7,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 88,04M | 18,47M | 7,53M | 94,59M | 70,43M |
| Net Income | -784,96M | -589,53M | -526,24M | -388,96M | -215,31M |
| EPS (Diluted) | -6,54 | -5,26 | -5,45 | -4,33 | -2,80 |
| Gross Profit | 77,91M | -320,93M | -322,59M | -146,23M | -89,51M |
| Operating Income | -612,26M | -536,25M | -496,21M | -324,20M | -186,31M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,42B | 1,40B | 824,32M | 1,01B | 841,32M |
| Total Liabilities | 2,08B | 1,54B | 1,21B | 1,12B | 597,46M |
| Shareholders' Equity | -659,63M | -135,37M | -386,32M | -107,90M | 243,86M |
| Total Debt | 1,28B | 788,68M | 755,77M | 750,30M | 269,93M |
| Cash & Equivalents | 882,22M | 94,86M | 113,02M | 65,58M | 112,67M |
| Current Assets | 916,98M | 1,11B | 628,05M | 795,19M | 535,67M |
| Current Liabilities | 202,45M | 179,67M | 102,68M | 84,62M | 71,86M |